Aspen Neuroscience
Personalized medicine begins with you
San Diego, United States · Founded 2018 · $339.0M raised
- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2018
- Business Model
- B2B
- Website
- aspenneuroscience.com
- Total Funding
- $339.0M
- Last Round
- $115.0M Series CNov 2025
- Rounds
- 4
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Aspen Neuroscience is a clinical-stage biotech developing ANPD001, the world's first autologous iPSC-derived neuron replacement therapy for Parkinson's disease. Using a patient's own skin cells reprogrammed into dopamine-producing neurons, the treatment eliminates immunosuppression requirements and is currently in Phase 1/2a clinical trials.
Summary
Aspen Neuroscience is a Biotech company based in San Diego, United States, founded in 2018. It has raised $339.0M in total across 4 rounds, most recently a $115.0M Series C round in Nov 2025. Investors include ARCH Venture Partners, OrbiMed and Revelation Partners.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Sign up to see all 4 events
Funding: Seed through Series C. Amounts, valuations, and investors where available.
Investors

ARCH Venture Partners
3 rounds
OrbiMed
2 rounds
Revelation Partners
2 rounds
Domain Associates
2 rounds
Frazier Life Sciences
1 round
GV
1 round

LYFE Capital
1 round

Axon Ventures
1 round
Kite, a Gilead Company
1 round
Balyasny Asset Management
1 round
Cormorant Asset Management
1 round
Prebys Ventures
1 round
Frazier Healthcare
1 round
Alexandria Venture Investments
1 round
Similar Companies

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aspen-neuroscience"><img src="https://indexed.vc/api/badge/company/aspen-neuroscience" alt="Aspen Neuroscience on Indexed.vc" width="260" height="76" /></a>
